BUZZ-Oncolytics Biotech Inc: Submits application for orphan drug status

Mon Feb 9, 2015 9:49am EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Canadian drug developer's stock up 11 pct at 59 Canadian cents, U.S.-listed shares up 13 pct at 47.4 cents

** Says submitted application for orphan drug designation for its experimental drug to treat high grade gliomas in pediatric patients

** FDA grants orphan drug designation status to products that treat rare diseases, providing incentives to sponsors developing drugs or biologics